Q linea
Stock
Stock
ISIN: SE0011527845
Ticker: QLINEA
SE0011527845
QLINEA
Price
Price
CHART BY
Frequently asked questions
What is Q linea's market capitalization?
The market capitalization of Q linea is $22.73M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Q linea?
Q linea's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.0621. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Q linea's stock?
Currently, 1 analysts cover Q linea's stock, with a consensus target price of $0.0744. Analyst ratings provide insights into the stock's expected performance.
What is Q linea's revenue over the trailing twelve months?
Over the trailing twelve months, Q linea reported a revenue of $212.78K.
What is the EBITDA for Q linea?
Q linea's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$18.07M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Q linea?
Q linea has a free cash flow of -$18.65M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Q linea have, and what sector and industry does it belong to?
Q linea employs approximately 127 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
What is the free float of Q linea's shares?
The free float of Q linea is 4.19B. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $22.73M
- EPS (TTM)
- -$0.0621
- Free Float
- 4.19B
- Revenue (TTM)
- $212.78K
- EBITDA (TTM)
- -$18.07M
- Free Cashflow (TTM)
- -$18.65M
Pricing
- 52W span
- $0.004964$0.535
Analyst Ratings
The price target is $0.0744 and the stock is covered by 1 analysts.
Buy
1
Hold
0
Sell
0
Information
Q-linea AB operates as a holding company. The firm engages in the development of inventive systems for in vitro diagnostics for infectious diseases. Its products include ASTar, ASTrID and Data. The company was founded by Jonas Sven Peter Jarvius, Bernitz Mats Bo Johan Nilsson, Jan Grawe and Johan Stenberg in April 2008 and is headquartered in Uppsala, Sweden.
- Employees
- 127
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- SE0011527845
- Primary Ticker
- QLINEA
Knockouts
Finance data from FactSet